2002 | 2003 | 2005 | 2006 | 2007
2007
FEBRUARY, 2007
EMAS 2006/2007 NEW recommendations on Postmenopausal Hormone Therapy
2006
following:
Conjugated Equine Estrogens and Coronary Heart Disease: The Women's Health Initiative Hsia J, Langer RD, Manson JE, Kuller L, Johnson KC, Hendrix SL, Pettinger M, Heckbert SR, Greep N, Crawford S, Eaton CB, Kostis JB, Caralis P, Prentice R.Arch Intern Med. 2006 Feb 13;166(3):357-65
Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. Grodstein F, Manson JE, Stampfer MJ. J Womens Health (Larchmt). 2006 Jan-Feb;15(1):35-44.
2005
FEBRUARY, 2005
EMAS position paper on Postmenopausal Hormone Therapy
by courtesy of MATURITAS, vol 51/1
2002/2003
JULY, 2002
WHI / HERS II trial
Heart and Estrogen/Progestin Replacement Study Follow-up (HERS II)
Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy (JAMA 2002;288:49-57)
Noncardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy (JAMA 2002;288:58-67
More Evidence, More Pessimism, editorial by Diana B. Petitti, MD (JAMA 2002;288:99-101)
Principal Results from the Women's Health Initiative Randomized Controlled Trial
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women (JAMA 2002;288:321-33)
Failure of Estrogen Plus Progestin Therapy for Prevention, editorial by Suzanne W. Fletcher and Graham A. Colditz (JAMA 2002;288:366-8)